Skip to main content
OpenTrials

Clinical trial condition

Primary Immunodeficiency Diseases

Explore clinical trials studying Primary Immunodeficiency Diseases. Study availability and eligibility vary by location and protocol.

161 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

Primary Immunodeficiency Diseases trial results

Completed

Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.

NCT00278954

Conditions
Agammaglobulinemia, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +26 more
Locations
  • Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
  • Family Allergy and Asthma Center PC Atlanta, Georgia, United States
  • Rush University Medical Centre, University Consultants in Allergy & Immunology Chicago, Illinois, United States
  • Childrens Hospital at Buffalo, Allergy Division Buffalo, New York, United States
View Trial Details
Completed

Subcutaneous Ig NextGen 16% in PID Patients

NCT00391131

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • The Canberra Hospital Garran, Australian Capital Territory, Australia
  • John Hunter Hospital New Lambton Heights, New South Wales, Australia
  • Sydney Children's Hospital Randwick, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
View Trial Details
Completed

Ig NextGen 10% in Patients With Primary Immune Deficiency (PID)

NCT00405184

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Flinders Medical Centre Adelaide, South Australia, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • The Alfred Hospital Melbourne, Victoria, Australia
  • The Royal Melbourne Hospital Melbourne, Victoria, Australia
View Trial Details
Completed

Retrospective Chart Review of Subcutaneous IgG Use in Infants

NCT01166074

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • University of South Florida Tampa, Florida, United States
  • Midwest Immunology Clinic Plymouth, Minnesota, United States
  • University Hospitals Case Medical Center Cleveland, Ohio, United States
View Trial Details
Completed

Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients

NCT00220766

Conditions
Agammaglobulinemia, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +24 more
Locations
  • Departments of Medicine and Microbiology Birmingham, Alabama, United States
  • National Jewish Medical and Researach Center Denver, Colorado, United States
  • International Center for Interdisciplinary Studies of Immunology Washington D.C., District of Columbia, United States
  • Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases

NCT04640142

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Octapharma Research Site Irvine, California, United States
  • Octapharma Research Site Centennial, Colorado, United States
  • Octapharma Research Site Port Saint Lucie, Florida, United States
  • Octapharma Research Site St. Petersburg, Florida, United States
View all 23 locations
View Trial Details

Related conditions